4556 — Kainos Laboratories Share Price
0.000.00%
Last trade - 00:00- ¥5bn
- ¥3bn
- ¥5bn
- 94
- 73
- 51
- 89
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.81 | ||
| Price to Tang. Book | 0.81 | ||
| Price to Free Cashflow | 23.84 | ||
| Price to Sales | 1 | ||
| EV to EBITDA | 2.68 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.87% | ||
| Return on Equity | 11% | ||
| Operating Margin | 18.18% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 4,670.78 | 4,609.42 | 4,257.86 | 4,614.73 | 4,923.25 | n/a | n/a | 2.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +19.1 | +0.07 | +7.49 | +19.41 | +7.32 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
KAINOS Laboratories, Inc. is pricipally engaged in researching, developing, manufacturing and selling clinical diagnostic reagents, including biochemical diagnostic reagents such as renal function related reagents and automatic biochemical analytical reagents, immune serological test reagents such as transfusion-related reagents, allergy-related reagents, cancer marker related reagents, and other reagents.
Directors
- Shiro Kamiji PRE (58)
- Yukihiro Nagatsu MDR
- Soji Endo EXO
- Dai Kaneko EXO
- Shigekazu Yamamoto EXO
- Shigeo Kobayashi EXO (59)
- Katsumi Matsumoto EXO (60)
- Sumio Shirai EXO
- Tsukasa Hayashi OTH
- Wataru Kurotani OTH (53)
- Keiichi Kamoshita IND (51)
- Kenji Kikuchi IND
- Takatoshi Ohtake IND
- Kazumasa Ohtsubo IND
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 1st, 1975
- Public Since
- December 4th, 1995
- No. of Shareholders
- 2,487
- No. of Employees
- 144
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 4,215,660
- Address
- 2-38-18, Hongo, BUNKYO-KU, 113-0033
- Web
- http://www.kainos.co.jp/
- Phone
- +81 338164123
- Auditors
- Ernst & Young ShinNihon LLC
Upcoming Events for 4556
Similar to 4556
Alfresa Holdings
Tokyo Stock Exchange
Asahi Intecc Co
Tokyo Stock Exchange
Aso International
Tokyo Stock Exchange
As One
Tokyo Stock Exchange
Atect
Tokyo Stock Exchange
FAQ
What is the Kainos Laboratories share price?
As of Today at 19:12 UTC, shares in Kainos Laboratories are trading at ¥1,185. This share price information is delayed by 15 minutes.
How has the Kainos Laboratories share price performed this year?
Shares in Kainos Laboratories last closed at ¥1,185 and the price had moved by +14.94% over the past 365 days. In terms of relative price strength the Kainos Laboratories share price has underperformed the Nikkei 225 Index by -13.5% over the past year.
What are the analyst and broker recommendations for Kainos Laboratories?
There is no consensus recommendation for this security.
What is the Kainos Laboratories dividend yield?
The Kainos Laboratories dividend yield is 2.11% based on the trailing twelve month period.
Does Kainos Laboratories pay a dividend?
Last year, Kainos Laboratories paid a total dividend of ¥25, and it currently has a trailing dividend yield of 2.11%.Looking ahead, the next dividend pay date is 2024-06-01.
When does Kainos Laboratories next pay dividends?
We do not have data on when Kainos Laboratories is to next pay dividends. The historic dividend yield on Kainos Laboratories shares is currently 2.11%.
How do I buy Kainos Laboratories shares?
To buy shares in Kainos Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kainos Laboratories?
As of the previous close price of ¥1,185, shares in Kainos Laboratories had a market capitalisation of ¥5bn.
Where are Kainos Laboratories shares listed?
Here are the trading details for Kainos Laboratories:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4556
What kind of share is Kainos Laboratories?
Based on an overall assessment of its quality, value and momentum Kainos Laboratories is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kainos Laboratories share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Kainos Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kainos Laboratories. Over the past six months, its share price has underperformed the Nikkei 225 Index by -4.96%.
As of the last closing price of ¥1,185, shares in Kainos Laboratories were trading +7.84% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kainos Laboratories PE Ratio?
The Kainos Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥1,185.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kainos Laboratories?
Kainos Laboratories' management team is headed by:
- Shiro Kamiji - PRE
- Yukihiro Nagatsu - MDR
- Soji Endo - EXO
- Dai Kaneko - EXO
- Shigekazu Yamamoto - EXO
- Shigeo Kobayashi - EXO
- Katsumi Matsumoto - EXO
- Sumio Shirai - EXO
- Tsukasa Hayashi - OTH
- Wataru Kurotani - OTH
- Keiichi Kamoshita - IND
- Kenji Kikuchi - IND
- Takatoshi Ohtake - IND
- Kazumasa Ohtsubo - IND